Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System

ClinicalTrials.gov ID

NCT05636527

Lead Sponsor

Endospan Ltd.INDUSTRY

Overall Status

Recruiting

Study Type

Observational

Enrollment

70Estimated

Last Update Posted

Dec 4, 2025Actual

Start Date

Nov 9, 2022Actual

Primary Completion Date

Mar 2027Estimated

Completion Date

Jul 2030Estimated

Official Title

A Non-Randomized, Prospective or Retrospective, Open-Label, Multi-Center, Observational Clinical Study With Two Arms to Further Evaluate Safety and Performance of the NEXUS® Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System

Brief Summary

The goal of this observational study is to collect clinical information on how safe, and how well the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO™ Aortic Arch Stent Graft System work for the treatment of aortic aneurysms, in the standard-of-care setting.

The main question[s] it aims to answer are:

• Early mortality
• Safety outcomes throughout the study
• Device failure throughout the study
• Procedural and hospitalisation information Participants will be treated per institutional standard of care Follow-up information will be collected through to five years.

• AAT9

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

1. Male and female age ≥18 years
2. The subject is indicated for implant of the NEXUS Aortic Arch System in accordance with the current IFU, or
3. The subject is indicated for implant of the custom-made NEXUS DUO Aortic Arch System in accordance with the current IFU, or
4. The subject has been already implanted, after February 2019, with the NEXUS or the NEXUS DUO according to the relevant IFU
5. The subject is able and willing to provide informed consent to participate in the study.
6. Subject is not currently enrolled in another investigational study or registry that would directly interfere with the current study, except if the subject is participating in a mandatory government registry, or a purely observational registry with no associated treatments. Each instance should be brought to the attention of the sponsor to determine eligibility.
7. In the opinion of the Investigator, life expectancy exceeds one year
8. The subject is not pregnant or planning to become pregnant.
9. In the physician's opinion, subject's renal function is stable for the NEXUS procedure.
10. In the opinion of the investigator, subject does not have co-morbidities or planned surgeries that will interfere with the implant of the device, e.g., major cardiac surgery or interventional procedure in the last 90 days, MI or cerebral vascular accident (CVA) in the last 90 days

Observational Model

Cohort

Time Perspective

Other

Lead Sponsor

Endospan Ltd.INDUSTRY

herzchirugie@dhzb.de

cibin.gio@gmail.com

• The Single Branch NEXUS™ Clinical Study

  NCT03208504

  CompletedInterventionalNot ApplicableUpdated Feb 22, 2023
• NEXUS™ Aortic Arch Stent Graft System First In Man Study

  NCT02365454

  CompletedInterventionalNot ApplicableUpdated Sep 21, 2023
• NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

  NCT04471909

  RecruitingInterventionalNot ApplicableUpdated Oct 20, 2025
• The NEXUS™ Compassionate Use Data Collection Study

  NCT03420066

  CompletedObservationalUpdated Jan 5, 2024
• Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction

  NCT07139912

  Not yet recruitingInterventionalNot ApplicableUpdated Aug 24, 2025
• French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft

  NCT05030740

  CompletedObservationalUpdated Feb 19, 2025